End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58,100 KRW | +0.35% | -2.19% | -19.31% |
May. 03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
ETFs positioned on SK bioscience Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.57% | 2 M€ | -14.14% | ||
0.78% | 14 M€ | -3.15% | ||
0.04% | 15 M€ | +21.38% | ||
0.02% | 2,867 M€ | +10.52% | - | |
0.02% | 454 M€ | +8.42% | - | |
0.02% | 153 M€ | +7.93% | - | |
0.02% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +4.91% | - | |
0.01% | 7 M€ | +5.57% | - | |
0.00% | 45 M€ | 0.00% | - | |
0.00% | 34 M€ | +9.41% | - | |
0.00% | 306 M€ | +6.74% | - | |
0.00% | 39 M€ | +6.13% | - | |
0.00% | 34 M€ | +4.00% | - | |
0.00% | 7 M€ | +0.11% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.31% | 3.27B | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.50% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-42.60% | 11.6B | |
-12.64% | 11.5B | |
+5.47% | 8.82B |
- Stock Market
- Equities
- A302440 Stock
- Funds and ETFs SK bioscience Co.,Ltd.